Rapid Micro Biosystems Inc (RPID)

Rapid Micro Biosystems Inc (RPID) is a Medical Devices company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $44.8M; returns 1 day -2.6%, 1 week +2.0%, 1 year -71.8%.

Rapid Micro Biosystems Inc (RPID) develops, manufactures, and commercializes the Growth Direct platform, an automated, non-destructive system for rapid microbial quality control testing in pharmaceutical manufacturing. The company generates revenue primarily through sales of Growth Direct systems (capital equipment), consumable cassettes used in testing, and related service contracts.

Groups RPID belongs to

• Healthcare
• Life Sciences
• Automation
• Industrial Manufacturing
• Pharmaceuticals
• Medical Devices
• Healthcare Equipment
• Quality Control
• Life Sciences Tools & Services
• Industrial Technology
• Biotechnology

RPID financial model: income statement, cash flow and balance sheet